Logo-apb
Research Article

1. Investigating Effect of Rapamycin and Metformin on Angiogenesis in Hepatocellular Carcinoma Cell Line
Mandana Rastegar, Haji-Amin Marjani, Yaghoub Yazdani, Majid Shahbazi, Masoud Golalipour*, Touraj Farazmandfar*
Adv Pharm Bull. 2018;8(1): 63-68. doi: 10.15171/apb.2018.008
PMCID: PMC5899784     PMID: 29670840     Scopus ID: 85044043482    
Article
PDF
XML
Cited By:
9
4
8
Short Communication

2. Kaempferol-Mediated Sensitization Enhances Chemotherapeutic Efficacy of Sorafenib Against Hepatocellular Carcinoma: An In Silico and In Vitro Approach
Bhagyalakshmi Nair ORCID, Ruby John Anto, Sabitha M, Lekshmi R. Nath* ORCID
Adv Pharm Bull. 2020;10(3): 472-476. doi: 10.34172/apb.2020.058
PMCID: PMC7335979     PMID: 32665908     Scopus ID: 85088613671    
Article
PDF
Full Text
XML
Cited By:
14
10
27
Research Article

3. The Effect of Alpha Mangostin on Epithelial-Mesenchymal Transition on Human Hepatocellular Carcinoma HepG2 Cells Surviving Sorafenib via TGF-β/Smad Pathways
Syarinta Adenina ORCID, Melva Louisa* ORCID, Vivian Soetikno, Wawaimuli Arozal, Septelia Inawati Wanandi
Adv Pharm Bull. 2020;10(4): 648-655. doi: 10.34172/apb.2020.078
PMCID: PMC7539313     PMID: 33062605     Scopus ID: 85090440518    
Article
PDF
Full Text
XML
Cited By:
5
1
5
Review Article

4. Nanomedicine Strategies Utilizing Lipid-Based Nanoparticles for Liver Cancer Therapy: Exploring Signaling Pathways and Therapeutic Modalities
Fereshteh Asgharzadeh ORCID, Maryam Moradi Binabaj, Sahar Fanoudi, William C. Cho, Yu-jeong Yang, Maryam Azarian, Mehdi Shafiee Ardestani, Nasim Nasiri, Marzieh Ramezani Farani* ORCID, Yun Suk Huh* ORCID
Adv Pharm Bull. 2024;14(3): 513-523. doi: 10.34172/apb.2024.061
PMCID: PMC11530870     PMID: 39494254    
Article
PDF
XML
Cited By:
0

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by